These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10914257)

  • 1. [Circadian fluctuations in the success and efficacy of streptokinase thrombolytic therapy in acute myocardial infarction].
    Goldhammer E; Kharash L; Abinader EG
    Harefuah; 1999 Mar; 136(6):434-7, 515. PubMed ID: 10914257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian fluctuations in the efficacy of thrombolysis with streptokinase.
    Goldhammer E; Kharash L; Abinader EG
    Postgrad Med J; 1999 Nov; 75(889):667-71. PubMed ID: 10621877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical aspects of thrombolytic therapy with streptokinase in myocardial infarct].
    Kharash LM; Gol'dkhammer EI; Abinader EG
    Ter Arkh; 1996; 68(12):53-7. PubMed ID: 9054042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
    Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
    Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.
    Shen L; Yang J; Hu Q; Teng Y; Han X; Yan S; Lian M; Xie M; Gu F
    Chin Med J (Engl); 1997 Jan; 110(1):53-5. PubMed ID: 9594323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
    Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolysis in myocardial infarction-outcome optimization methods].
    Kharash LM; Goldhammer EI; Abinader EI
    Klin Med (Mosk); 1998; 76(9):25-9. PubMed ID: 9821369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility of patients with acute myocardial infarction for thrombolytic therapy: retrospective cohort study.
    Zaputović L; Mavrić Z; Mlinarić B; Kupanovac Z; Matana A; Marinović D
    Croat Med J; 2000 Dec; 41(4):401-5. PubMed ID: 11063763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repeat thrombolysis in acute myocardial infarction].
    Király C; Timár S
    Orv Hetil; 2001 Apr; 142(13):665-9. PubMed ID: 11338569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase.
    Wong CK; French JK; Gao W; White HD
    Am Heart J; 2003 Jan; 145(1):95-102. PubMed ID: 12514660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rescue thrombolysis with repeated doses of streptokinase in acute myocardial infarct. A preliminary report].
    Arriaga Nava R; Olivas Bojórquez M; Jerjes-Sánchez C
    Arch Inst Cardiol Mex; 1995; 65(4):323-9. PubMed ID: 8561653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.